[1]
Bischof , K. et al. 2026. Oncological outcome and immune-checkpoint-blockade-induced toxicities in patients with cervical cancer – a Norwegian real-world cohort. Acta Oncologica. 65, (Jun. 2026), 518–524. DOI:https://doi.org/10.2340/1651-226X.2026.45737.